|
Descripción
|
|
|---|---|
| Food-specific immunotherapy (sIT) is a promising treatment for LTP-syndrome. Although sublingual sIT (SLIT) has been shown as safe and effective, it is less so than oral immunotherapy. The use of T-cell peptides from major allergens can increase effec- tiveness without increasing IgE reactivity. Moreover, their weak responses may be enhanced using Toll-like receptor ligands as adju- vants. We propose a novel SLIT that combines a Pru p 3 peptide and a ODN with CpG motifs (ODN-CpG) to induce a specific Th1/ Treg response. | |
|
Internacional
|
Si |
|
Nombre congreso
|
EAACI Congress 2017 |
|
Tipo de participación
|
970 |
|
Lugar del congreso
|
|
|
Revisores
|
Si |
|
ISBN o ISSN
|
0105-4538 |
|
DOI
|
|
|
Fecha inicio congreso
|
17/06/2017 |
|
Fecha fin congreso
|
21/06/2017 |
|
Desde la página
|
722 |
|
Hasta la página
|
722 |
|
Título de las actas
|
ABSTRACTS, SUNDAY 18th JUNE 2017 |